ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 166 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $22,745,000 | +7.8% | 638,000 | 0.0% | 0.10% | +10.5% |
| Q3 2015 | $21,099,000 | -21.2% | 638,000 | -0.2% | 0.10% | -9.5% |
| Q2 2015 | $26,766,000 | +35.3% | 639,100 | +5.3% | 0.10% | +36.4% |
| Q1 2015 | $19,785,000 | +25.2% | 607,100 | +22.0% | 0.08% | +22.2% |
| Q4 2014 | $15,797,000 | +27.1% | 497,530 | -0.9% | 0.06% | +23.5% |
| Q3 2014 | $12,432,000 | +25.9% | 502,100 | +14.9% | 0.05% | +30.8% |
| Q2 2014 | $9,872,000 | -17.6% | 437,000 | -11.3% | 0.04% | -20.4% |
| Q1 2014 | $11,981,000 | – | 492,442 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |